Health Science Reports
Stroke Reduction Therapies, Shared Decision‐Making, and Patient Decision Aids: An Opportunity for Improved Quality and Inclusion in the Management of Atrial Fibrillation—A Perspective Piece
ABSTRACT Background Atrial fibrillation (AF) is associated with 20% of the ischemic strokes in the United States. Atrial fibrillation related ischemic strokes can be reduced by pharmacologic and non‐pharmacologic therapies. The decision‐making process for selecting stroke reduction therapies is complex and should be individualized based on patient preferences and values, the risk and benefits of treatment, and the impact on the quality of life. Shared decision‐making (SDM) operationalized through patient decision a …